April 8, 2014The Power of Mobilizing the Immune System for Cancer Therapy
Heralded as the “Breakthrough of 2013” by the leading scientific journal Science, cancer immunotherapy is finally getting the attention many in the field thought it long deserved.
March 4, 2014New Treatment Protocol for Rectal Cancer Saves Pregnant Woman and Her Baby
A few weeks after she learned she was pregnant with her first child, Michelle Jahnke was diagnosed with stage 3 rectal cancer. A novel approach by her UCM team saved her and her baby.
February 19, 2014Collaboration Drives Cancer Epigenome Mapping and Translation to the Clinic
Sometimes it takes a new discovery to put puzzling research findings into the right framework Read more »
February 4, 2014Thyroid Cancer Research’s Storied Past and Promising Future
At first glance, it may seem ironic that the same institution that gave the world the first nuclear self-sustaining chain reaction also made the first link between radiation exposure and thyroid cancer. Our surgical team: Edwin Kaplan, MD, left, Raymon Grogan, MD, and Peter Angelos, MD.
January 6, 2014University of Chicago to Share in $540 Million Gift from Ludwig Cancer Research
Ludwig Center at the University of Chicago receives $90 million to support research on cancer metastasis. Center directors Ralph Weichselbaum, MD, left, and Geoffrey Greene, PhD.
Recent Posts by UChicago Cancer Experts
Pediatric oncologist and co-leader of the Clinical Trials Cluster at the Institute for Translational Medicine, Susan Cohn, MD, has been named dean for Clinical Research at the University of Chicago Medicine & Biological Sciences.
Protein function is controlled by many factors and can be dictated by the distinct array of modifications that occur after proteins are synthesized. The recent publication of two high-impact research papers by biochemist and cancer biologist Yingming Zhao, PhD, is charting new territory in the understanding of post-translational modifications.
How are we doing since President Nixon declared war on cancer by signing the National Cancer Act in 1971? The chief medical officer of the American Cancer Society says that while cancer deaths are declining, the economic burden of cancer care, coupled with an unsustainable rate of health care consumption, spells trouble for the future.
A legacy of knowledge, kindness and collaboration will be honored in the first Sylvia Watson Award for Excellence in Ambulatory Oncology Nursing Practice to be presented at the Nursing Excellence Awards Ceremony in May.
Researchers have found that a protein, which normally suppresses tumor growth when it’s inside the nucleus, has the opposite effect when hypoxia associated with rapidly multiplying kidney cancer cells drives the protein out into the cytoplasm.